Syneos Health Investor Relations Material
Latest events
Q4 2022
Syneos Health
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Syneos Health Inc
Access all reports
Syneos Health, Inc., a biopharmaceutical solutions company, provides outsourced clinical development, and commercialization services for biopharmaceutical and medical device industries in North America, Europe, the Middle East, Africa, the Asia Pacific & Russia. The company offers integrated solutions for Phase I to Phase IV clinical trials; and late phase trials, including observational research studies and outcome-based registries.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
SYNH
Country
🇺🇸 United States